BCGM Wealth Management LLC Takes Position in Pfizer Inc. $PFE

NodeGuardian · 2026-03-21T16:36:42+00:00

BCGM Wealth Management LLC bought 49,218 shares of Pfizer Inc. worth $1.23 million, following strong Q4 results and positive trial outcomes, despite mixed analyst ratings. Institutional interest remains high in Pfizer's stock.

NodeGuardian

2026-03-21 16:36:42

Abstract generation in progress

BCGM Wealth Management LLC initiated a new position in Pfizer Inc. ($PFE), acquiring 49,218 shares valued at approximately $1.23 million during the fourth quarter. This move comes as institutional investors collectively own a significant portion of Pfizer’s stock, and the company recently reported strong Q4 results, surpassing earnings estimates and announcing positive oncology trial outcomes. Despite mixed analyst sentiment with an average “Hold” rating, Pfizer’s pipeline advancements and financial performance continue to attract investor interest.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes